http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104622828-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2015-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104622828-B
titleOfInvention A kind of preparation method of puerarin sustained-release dropping pills
abstract The present invention relates to a kind of preparation method of puerarin sustained-release dropping pills, it is comprised the following steps that:(1) hydrophobic base and hydrophilic matrix are weighed, fully melting is mixed under condition of water bath heating, adds Puerarin powder, be well mixed;(2) start pill, preheat 30min;(3) start pill dripping machine stirring system, stir 10min;(4) open condensate liquid liquid level adjusting knob, regulation drop away from;(5) water dropper is installed in pill dripping machine;(6) decoction is instilled in condensate liquid;(7) sustained-release dropping pill is collected;(8) condensate liquid on sustained-release dropping pill surface is blotted with filter paper and hospital gauze, puerarin sustained-release dropping pills are produced.The optimal preparation technology of the invention for preferably going out Puerarin novel form sustained-release dropping pill, can reach drug loosed time, reduce the purpose of toxic side effect, it can reduce simultaneously and take number of times, the purpose of patient medication compliance is improved, is that medicine enterprise and clinical development provide important references with larger clinical value.
priorityDate 2015-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281

Total number of triples: 27.